Literature DB >> 3117700

Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis.

A Bauernfeind1, R M Bertele, K Harms, G Hörl, R Jungwirth, C Petermüller, B Przyklenk, C Weisslein-Pfister.   

Abstract

A microbiological analysis of 102 patients suffering from cystic fibrosis was conducted over a 22 month period. 20 microbial species with the following incidence were identified: Pseudomonas aeruginosa: 83.4%; Candida albicans: 29.4%; Staphylococcus aureus: 24.5%; Staphylococcus epidermidis: 11.8%; Haemophilus influenzae: 11.8%; Streptococcus pneumoniae; 6.9%; Pseudomonas maltophilia: 6.8%; Aspergillus fumigatus: 5.9%. Other species were present in less than 5% of the patients. In the majority of specimens with P. aeruginosa, more than one type (up to six) was detectable. These strains were identical in colony appearance, O-serotype and pyocin-type. Quantitative analysis revealed concentrations of colony-forming units of 10(7) to 10(9) for P. aeruginosa, 10(6) to 10(8) for P. maltophilia, 10(4) to 10(7) for S. aureus, 10(4) to 10(6) for S. epidermidis and 10(4) to 10(7) for C. albicans in the majority of specimens. Significant differences were observed in the time periods during which the pathogens persisted in the patients. Maximum persistence was observed for P. aeruginosa. P. maltophilia and A. fumigatus had about similar persistence rates, which were lower than those for P. aeruginosa but above those for S. aureus and H. influenzae. S. epidermidis was eliminated within shorter periods than S. aureus. C. albicans, although the second most frequent microorganism identified, showed a very low persistence rate. The microbiological analysis confirms results from other research centers (high incidence of P. aeruginosa), but reveals significant regional differences as well (Pseudomonas cepacia not detectable, higher incidence of P. maltophilia and C. albicans). This underlines the necessity for detailed qualitative and quantitative microbiological analysis of sputa from cystic fibrosis patients as a prerequisite for rational analysis of etiological, epidemiological and therapeutical aspects of cystic fibrosis.

Entities:  

Mesh:

Year:  1987        PMID: 3117700     DOI: 10.1007/bf01644137

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  20 in total

1.  A simple test system for the separation of staphylococci from micrococci.

Authors:  K H Schleifer; W E Kloos
Journal:  J Clin Microbiol       Date:  1975-03       Impact factor: 5.948

2.  Sputum bacteriology in patients with cystic fibrosis in a Toronto hospital during 1970-1981.

Authors:  M Corey; L Allison; C Prober; H Levison
Journal:  J Infect Dis       Date:  1984-02       Impact factor: 5.226

3.  Selective procedure to isolate haemophilus influenzae from sputa with large quantities of Pseudomonas aeruginosa.

Authors:  A Bauernfeind; K Rotter; C Weisslein-Pfister
Journal:  Infection       Date:  1987 Jul-Aug       Impact factor: 3.553

Review 4.  Why is Pseudomonas the colonizer and why does it persist?

Authors:  R Ramphal; S Vishwanath
Journal:  Infection       Date:  1987 Jul-Aug       Impact factor: 3.553

Review 5.  Rational parameters for antibiotic therapy in patients with cystic fibrosis.

Authors:  J R Govan; C Doherty; S Glass
Journal:  Infection       Date:  1987 Jul-Aug       Impact factor: 3.553

6.  Frequency of Aspergillus fumigatus isolates and antibodies to aspergillus antigens in cystic fibrosis.

Authors:  H Schønheyder; T Jensen; N Høiby; P Andersen; C Koch
Journal:  Acta Pathol Microbiol Immunol Scand B       Date:  1985-04

7.  Cultures of thoracotomy specimens confirm usefulness of sputum cultures in cystic fibrosis.

Authors:  M J Thomassen; J D Klinger; S J Badger; D W van Heeckeren; R C Stern
Journal:  J Pediatr       Date:  1984-03       Impact factor: 4.406

8.  Selective media for the quantitation of bacteria in cystic fibrosis sputum.

Authors:  K Wong; M C Roberts; L Owens; M Fife; A L Smith
Journal:  J Med Microbiol       Date:  1984-04       Impact factor: 2.472

9.  Allergic bronchopulmonary aspergillosis complicating cystic fibrosis in childhood.

Authors:  M J Brueton; L P Ormerod; K J Shah; C M Anderson
Journal:  Arch Dis Child       Date:  1980-05       Impact factor: 3.791

10.  Bacteriology of sputum in cystic fibrosis: evaluation of dithiothreitol as a mucolytic agent.

Authors:  M R Hammerschlag; L Harding; A Macone; A L Smith; D A Goldmann
Journal:  J Clin Microbiol       Date:  1980-06       Impact factor: 5.948

View more
  53 in total

Review 1.  Bacterial-fungal interactions: hyphens between agricultural, clinical, environmental, and food microbiologists.

Authors:  P Frey-Klett; P Burlinson; A Deveau; M Barret; M Tarkka; A Sarniguet
Journal:  Microbiol Mol Biol Rev       Date:  2011-12       Impact factor: 11.056

Review 2.  Quorum-sensing blockade as a strategy for enhancing host defences against bacterial pathogens.

Authors:  Thomas Bjarnsholt; Michael Givskov
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2007-07-29       Impact factor: 6.237

3.  Susceptibility to various antimicrobial agents of Staphylococcus aureus isolates from cystic fibrosis patients.

Authors:  S Ballestero; R Villaverde; H Escobar; F Baquero
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-12       Impact factor: 3.267

Review 4.  The innate immune system in cystic fibrosis lung disease.

Authors:  R Bals; D J Weiner; J M Wilson
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

5.  Precipitating Pseudomonas aeruginosa antibodies and antimicrobial therapy in cystic fibrosis patients.

Authors:  M Trancassini; D de Vito; G Cimino; M Antonelli; S Quattrucci; P Cipriani
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-04       Impact factor: 3.267

Review 6.  Medically important bacterial-fungal interactions.

Authors:  Anton Y Peleg; Deborah A Hogan; Eleftherios Mylonakis
Journal:  Nat Rev Microbiol       Date:  2010-03-29       Impact factor: 60.633

7.  Genotypic characterization of sequential Aspergillus fumigatus isolates from patients with cystic fibrosis.

Authors:  P E Verweij; J F Meis; J Sarfati; J A Hoogkamp-Korstanje; J P Latgé; W J Melchers
Journal:  J Clin Microbiol       Date:  1996-10       Impact factor: 5.948

Review 8.  Interaction of Candida albicans with host cells: virulence factors, host defense, escape strategies, and the microbiota.

Authors:  Sarah Höfs; Selene Mogavero; Bernhard Hube
Journal:  J Microbiol       Date:  2016-02-27       Impact factor: 3.422

9.  Identification and detection of Stenotrophomonas maltophilia by rRNA-directed PCR.

Authors:  P W Whitby; K B Carter; J L Burns; J A Royall; J J LiPuma; T L Stull
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

Review 10.  The role of inflammation in the pathophysiology of CF lung disease.

Authors:  James F Chmiel; Melvin Berger; Michael W Konstan
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.